Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.

Abstract

This follow-up study measures the antibody response following the second dose of SARS-CoV-2 mRNA vaccine in recipients of solid organ transplants.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood*
  • COVID-19 / immunology*
  • COVID-19 Vaccines / immunology*
  • Female
  • Humans
  • Immunization, Secondary
  • Male
  • Middle Aged
  • Organ Transplantation
  • SARS-CoV-2 / immunology*
  • Spike Glycoprotein, Coronavirus / immunology*
  • Transplant Recipients*
  • Vaccines, Synthetic / immunology
  • Young Adult
  • mRNA Vaccines

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • Vaccines, Synthetic
  • spike protein, SARS-CoV-2